The total return over the past 12 months is +17.94% vs. +16.94% for the S&P 500. So far it's up +32.81% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +15.73% | (5.49%) | (4.23%) | +2.03% | +7.18% | +4.09% |
| Total Return CAGR | +17.94% | (3.70%) | (2.70%) | +3.50% | +8.99% | +6.40% |
| Revenue CAGR | (7.00%) | (11.40%) | (4.75%) | (1.10%) | +1.34% | +1.21% |
| Net Income CAGR | (16.47%) | (15.28%) | +0.89% | (1.92%) | +3.41% | +1.50% |
| EPS CAGR | (12.30%) | (8.41%) | +3.36% | +1.03% | +5.06% | +3.05% |
| Free Cash Flow CAGR | (16.74%) | (20.02%) | (11.12%) | (3.03%) | +3.33% | +0.90% |
| Operating Cash Flow CAGR | (16.16%) | (19.95%) | (10.83%) | (2.84%) | +2.71% | +0.90% |
| Dividends CAGR | +1.64% | +1.67% | +1.70% | +1.73% | +1.83% | +2.61% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Utah Medical Products, Inc. (UTMD)
| Year | Start price | End price | UTMD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $55.96 | $73.31 | +32.81% | +14.51% | +18.30% |
| 2025 | $61.47 | $55.96 | (7.03%) | +17.72% | (24.75%) |
| 2024 | $84.22 | $61.47 | (25.68%) | +24.89% | (50.57%) |
| 2023 | $100.53 | $84.22 | (15.11%) | +26.19% | (41.30%) |
| 2022 | $100.00 | $100.53 | +1.85% | (18.17%) | +20.02% |
| 2021 | $84.30 | $100.00 | +19.78% | +28.74% | (8.96%) |
| 2020 | $107.90 | $84.30 | (20.87%) | +18.37% | (39.24%) |
| 2019 | $83.08 | $107.90 | +31.44% | +31.22% | +0.22% |
| 2018 | $81.40 | $83.08 | +3.24% | (4.56%) | +7.80% |
| 2017 | $72.75 | $81.40 | +13.59% | +21.70% | (8.11%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
